The Discounted Cash Flow (DCF) valuation of Genovis AB (GENO.ST) is 15.14 SEK. With the latest stock price at 28.55 SEK, the upside of Genovis AB based on DCF is -47%.
Based on the latest price of 28.55 SEK and our DCF valuation, Genovis AB (GENO.ST) is a sell. Selling GENO.ST stocks now will result in a potential gain of 47%.
Range | Selected | |
WACC / Discount Rate | 5.1% - 8.2% | 6.7% |
Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
Fair Price | 8.78 - 146.63 | 15.14 |
Upside | -69.3% - 413.6% | -47.0% |
(SEK in millions) | Projections | |||||
12-2024 | 12-2025 | 12-2026 | 12-2027 | 12-2028 | 12-2029 | |
Revenue | 130 | 142 | 182 | 206 | 227 | 246 |
% Growth | 18% | 9% | 28% | 13% | 10% | 9% |
Cost of goods sold | (46) | (48) | (58) | (63) | (65) | (67) |
% of Revenue | 35% | 34% | 32% | 30% | 29% | 27% |
Selling, G&A expenses | (45) | (49) | (62) | (71) | (78) | (85) |
% of Revenue | 34% | 34% | 34% | 34% | 34% | 34% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
% of Revenue | 0% | 0% | 0% | 0% | 0% | 0% |
Net interest & other expenses | 7 | 8 | 10 | 11 | 12 | 13 |
% of Revenue | 5% | 5% | 5% | 5% | 5% | 5% |
Tax expense | (13) | (15) | (21) | (24) | (28) | (31) |
Tax rate | 29% | 29% | 29% | 29% | 29% | 29% |
Net profit | 33 | 38 | 50 | 59 | 68 | 76 |
% Margin | 25% | 27% | 28% | 29% | 30% | 31% |